Kazia Therapeutics Ltd (NAS:KZIA)
$ 12 -0.32 (-2.6%) Market Cap: 186.60 Mil Enterprise Value: 140.51 Mil PE Ratio: 0 PB Ratio: 4.41 GF Score: 33/100

Kazia Therapeutics Ltd Corporate Call Transcript

Sep 01, 2026 / 12:00PM GMT
Release Date Price: $12.63 (-8.28%)
Operator

Good morning and welcome to Kazia Therapeutics' corporate update call.

(Operator Instructions) Please note that today's call is being recorded.

Before we begin, I would like to direct your attention to the forward-looking statements disclaimer displayed on the screen. We encourage you to review this information, which applies to the statements made during today's presentation.

I'd now like to turn the call over to Dr. John Friend, Chief Executive Officer.

John Friend
Kazia Therapeutics Ltd - Interim Chairman of the Board, Chief Executive Officer, Managing Director

Thank you, Rob. I don't see the slides, but that's okay. I think we've talked about this. So if you can put them up on our screen, that'd be very helpful. All right. Good morning, everybody, and thank you for joining us today. On behalf of Kazia Therapeutics, I appreciate your time to participate in today's investor call.

I'm joined today by our Chief Professor Sudha Rao. Together, we'll provide a corporate and clinical update following several recent

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot